Evidence map›Paper›PMID 40458141›Full record

ArticleJDS communications2025

No indication of highly pathogenic avian influenza infections in Dutch cows.

N D Fabri, I M G A Santman-Berends, C A J Roos, G van Schaik, J Het Lam, E A Germeraad, M H Mars

Abstract read
In one paragraph

Article in JDS communications, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Detection of antibodies against avian influenza in European dairy cattle, the Netherlands, January 2026.Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin · 2026
    Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

N D FabriRoyal GD, 7418 EZ Deventer, the Netherlands.
I M G A Santman-BerendsRoyal GD, 7418 EZ Deventer, the Netherlands.
C A J RoosRoyal GD, 7418 EZ Deventer, the Netherlands.
G van SchaikRoyal GD, 7418 EZ Deventer, the Netherlands.
J Het LamRoyal GD, 7418 EZ Deventer, the Netherlands.
E A GermeraadWageningen Bioveterinary Research, 8221 RA Lelystad, the Netherlands.
M H MarsRoyal GD, 7418 EZ Deventer, the Netherlands.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In March 2024, an infection with highly pathogenic avian influenza (HPAI) virus subtype H5N1 of the HA clade 2.3.4.4b was detected in dairy cows in Texas. Following this first detection, the virus was identified in multiple states in the United States, with spillover into other mammals. This raised concerns in the Netherlands that despite having an effective monitoring and surveillance system, H5N1 virus infections in Dutch cattle could have occurred. The aim of this study was therefore to retrospectively screen Dutch cattle for HPAI virus infections for the period between 2022 and 2024. A total of 2,190 archived cattle serum samples from 367 different herds were selected, with an average of 6 samples per herd. These samples were tested using an influenza A blocking ELISA. A Luminex H5/H7 assay was used to confirm and subtype ELISA-positive samples. The influenza A blocking ELISA detects antibodies against all influenza A virus subtypes, whereas the Luminex assay can differentiate antibodies against the surface proteins haemagglutinin (HA or H) 5 and 7 (H5/H7), and neuraminidases (NA or N) 1 to 9 (N1-N9). Four samples (0.2%) reacted positive in the influenza A blocking ELISA, all from different herds located in different parts of the Netherlands. However, all 4 samples tested negative in the Luminex H5/H7 assay, indicating that the samples did not have antibodies against H5, H7, and N1 to N9. The 99.8% specificity of the ELISA may explain the ELISA-positive results. The ELISA used in this study is a multispecies test that has not yet been validated for use in cattle. The duration of detectable antibodies in cattle is unknown, as is the sensitivity to detect past infections with influenza A virus subtypes in cattle for the Dutch situation. Therefore results should be interpreted with caution. The lack of detected antibody responses in cattle in the Netherlands from 2022 to 2024 aligns with the absence of any indication for clinical cases in Dutch cattle over recent years in the national monitoring and surveillance system.

Identifiers

PMID40458141
PMCPMC12126829

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.